Engaging a flexible third party medical product development firm to help you tackle an inflexible process

Medical technology innovators learn quickly that there is little, if any, flexibility in the FDA approval process. NFANT Labs knew they needed multidisciplinary partners able to build flexibility into an inflexible process, designing and developing their product with a constant eye on efficiency and the FDA approval prize. In the United States, up to 70%…

An Evening of Medical Device Development: The FDA and Pediatric Medical Devices

“Children aren’t little adults, yet we expect our physicians to retrofit adult devices to fit a pediatric patient,” says Sherry Farrugia, Chief Operating and Strategy Officer of the Pediatric Technology Center, and Director of Children’s Healthcare of Atlanta Partnership. “When adult devices are used it can often cause safety concerns in surgery, orthopedics – really…

Talking bioskills training and medical device development with Georgia’s top surgeons

  Connect with GCMI and T3 Labs at GSACS 2017! The Georgia Society of the American College of Surgeons (GSACS) promotes elevation in standards of surgical care. Each year, the society meets for an annual meeting aimed at further educating surgeons for the benefit of the healthcare system. GCMI and its subsidiary T3 Labs is…

Fostering Medical Innovation in the Clinical Setting: Piedmont Innovations & GCMI

Who better to address unmet clinical needs and life-changing improvements to medical devices of all types than clinicians themselves? Piedmont Healthcare and T3 Labs’ a subsidiary of  GCMI, embark on a journey to create a self-sustaining innovation enterprise: concept to commercialization. All I.J. was trying to do was celebrate a friend’s wedding at the beach.…

The importance of innovators working with third party design firms to get novel medical technologies to market

GCMI and T3 Labs CEO Tiffany Wilson shares insights with Assembly Magazine on what it takes to bring a medical device from concept to commercialization. Developing a new medical technology is not for the faint of heart. It is a daunting, expensive, arduous process, but nevertheless, it is highly rewarding. The developmental pathway is enough…

Improving patient outcomes through research and medtech innovation with confidence: Dr. Robert Matheny’s T3 narrative

Having a facility like T3 to test novel and breakthrough applications’ ability to save lives is crucial for battling diseases and disorders. Dr. Matheny and the original team of T3 recognized the need and saw to it that it was met. The change in landscape for innovators was born from desperation and a desire to…

Igniting medtech innovation: How GCMI assists university-based and physician innovators bring new products to market

  GCMI and T3 Labs CEO Tiffany Wilson shares medtech development pathway insights in Medical Product Outsourcing. Bringing a new medical device from concept to cure to commercialization is an intimidating, complex and expensive process which often stifles innovation instead of encouraging it. Yet there remains a tremendous need and viable markets for medtech innovation…